Hospira plant under fire for violations

Pharmaceutical giant Hospira has been pulled up by US regulators for numerous violations found at its Melbourne-based manufacturing facility.

Located in Mulgrave, the Hospira plant received a stern warning letter from the US Food and Drug Administration (FDA) in September, following an inspection earlier in the year that identified a number of violations, The Australian reported.

However, the TGA